ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
170 hedge funds and large institutions have $2.3B invested in Intra-Cellular Therapies Inc. in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 66 reducing their positions, and 29 closing their positions.
Holders
170
Holders Change
-8
Holders Change %
-4.49%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
23
Increased
50
Reduced
66
Closed
29
Calls
$22.7M
Puts
$18.3M
Net Calls
+$4.39M
Net Calls Change
-$4.39M
Top Buyers
| 1 |
1
Lord, Abbett & Co
Jersey City,
New Jersey
|
$72M |
| 2 |
2
Franklin Resources
San Mateo,
California
|
$39.6M |
| 3 |
TCM
3
TimesSquare Capital Management
New York
|
$41.6M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$10.3M |
| 5 |
5
BlackRock
New York
|
$209M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$27.1M |
| 2 |
MWNA
2
Marshall Wace North America
New York
|
$0 |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$26.6M |
| 4 |
SC
4
Samlyn Capital
New York
|
$46.5M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$9.54M |